Embolic protection devices in percutaneous coronary intervention

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Biology

Background:

• Clinical benefit of percutaneous coronary intervention (PCI) relies on successful lesion treatment and restored macro/microvascular perfusion.
• Embolization during PCI is common in acute coronary syndrome and saphenous vein graft (SVG) lesions, impairing distal perfusion despite epicardial success.
• Microvascular dysfunction post-PCI can occur in up to 25% of patients, necessitating strategies to protect distal tissue.

Purpose of the Study:

• To evaluate the role of embolic protection devices (EPDs) in preventing distal embolization and improving outcomes during PCI.
• To assess the effectiveness of EPDs in different patient populations, specifically those with SVG lesions versus acute coronary syndrome (ACS).

Main Methods:

• Review of studies investigating EPDs as adjunctive therapy during PCI.
• Analysis of EPD performance in patients with SVG lesions compared to patients with ACS, including ST-elevation myocardial infarction (STEMI).

Main Results:

• EPDs have shown validated effectiveness in protecting microvascular circulation and reducing adverse events in SVG lesion PCI.
• EPDs failed to demonstrate significant effectiveness in improving outcomes for ACS patients undergoing PCI, including those with STEMI.

Conclusions:

• Embolic protection devices are beneficial for SVG interventions, improving microvascular perfusion.
• Current evidence does not support the routine use of EPDs in ACS patients undergoing PCI due to lack of demonstrated efficacy.